Protagenic Therapeutics, Inc.
Support and Resistance Levels
Past performance
News About PTIX
All events for PTIX
All deals for PTIX
Financial Ratios
Financial Statements
PTIX vs Sector & Peers
About Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. operates as a biopharmaceutical firm dedicated to the research and development of novel treatments designed to address neuropsychiatric and mood conditions exacerbated by stress. Foremost among its investigational products is PT00114, a laboratory-synthesized version of the teneurin carboxy-terminal associated peptide. This compound functions by emulating an innate brain signaling peptide, known for its ability to temper exaggerated stress reactions. The company's headquarters are located in New York, New York. Website protagenic.com
Headquarters New York City, NY, US